Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-01 Sale | 2023-03-03 7:53 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks | 10,988 | $45.65 | $501,602 | 104,115 (Direct) | View |
| 2022-03-01 Sale | 2022-03-03 6:09 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks | 3,234 | $66.62 | $215,449 | 75,940 (Direct) | View |
| 2021-10-14 Sale | 2021-10-18 6:55 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl EVP & Chief Tech Ops Officer | 358 | $81.14 | $29,048 | 40,148 (Direct) | View |
| 2021-05-06 Sale | 2021-05-10 6:14 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl EVP & Chief Tech Ops Officer | 363 | $113.68 | $41,266 | 40,506 (Direct) | View |
| 2021-03-01 Sale | 2021-03-03 8:39 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl EVP & Chief Tech Ops Officer | 4,255 | $138.18 | $587,956 | 51,761 (Direct) | View |
| 2020-10-14 Sale | 2020-10-16 7:18 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl EVP & Chief Tech Ops Officer | 262 | $88 | $23,056 | 34,699 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-01 Option Award | 2025-03-04 8:02 pm | N/A 2035-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks | 59,011 | $0 | 140,665 (Direct) | View |
| 2025-03-03 Tax Withholding | 2025-03-04 8:02 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks | 1,348 | $42.92 | 140,665 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-05 8:17 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks | 470 | $53.69 | 114,402 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 8:17 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks | 50,157 | $0 | 114,402 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 7:53 pm | N/A 2033-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks | 64,063 | $0 | 104,115 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 6:09 pm | N/A 2032-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks | 38,900 | $0 | 75,940 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 8:39 pm | N/A 2031-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl EVP & Chief Tech Ops Officer | 21,136 | $0 | 51,761 (Direct) | View |